Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C40H39F5N4O3 |
| Molecular Weight | 718.7547 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C(CCC5=C(F)C(F)=CC=C5)=CC(=O)C6=C4N=CC=C6
InChI
InChIKey=OBJKLVFDRLAGJI-UHFFFAOYSA-N
InChI=1S/C40H39F5N4O3/c1-52-23-22-47-20-17-32(18-21-47)48(25-27-7-9-28(10-8-27)29-11-14-31(15-12-29)40(43,44)45)37(51)26-49-33(16-13-30-4-2-6-35(41)38(30)42)24-36(50)34-5-3-19-46-39(34)49/h2-12,14-15,19,24,32H,13,16-18,20-23,25-26H2,1H3
| Molecular Formula | C40H39F5N4O3 |
| Molecular Weight | 718.7547 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18214661
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18214661
Goxalapladib (SB-677116) is a selective inhibitor of Lipoprotein associated phospholipase A2 (Lp-PLA2).
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:27:28 GMT 2025
by
admin
on
Mon Mar 31 18:27:28 GMT 2025
|
| Record UNII |
GNG9ZD197L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID40961606
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107344
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
300000037018
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
GNG9ZD197L
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
8702
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
C72987
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
11686305
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
RR-59
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY | |||
|
412950-27-7
Created by
admin on Mon Mar 31 18:27:29 GMT 2025 , Edited by admin on Mon Mar 31 18:27:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|